Navigation Links
Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
Date:1/7/2009

rogate endpoint of overall response rate. It was approved by the FDA in February of 2002 as the first radioimmunotherapeutic agent for the treatment of NHL.

Rare deaths associated with an infusion reaction symptom complex have occurred within 24 hours of rituximab (Rituxan(R)) infusions. Yttrium-90 Zevalin administration results in severe and prolonged cytopenias in most patients. Severe cutaneous and mucocutaneous reactions have been reported. The most serious adverse reactions of the Zevalin therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia and anemia. Infusion-related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity correlated with the degree of bone marrow involvement prior to Zevalin therapy. Myelodysplasia or acute myelogenous leukemia was observed in 2 percent of patients (8 to 34 months after treatment). Zevalin should only be used by health care professionals qualified by training and experience in the safe use of radionuclides.

Patients and healthcare professionals can visit www.zevalin.com for more information.

About Non-Hodgkin's Lymphoma

Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms - aggressive NHL, a rapidly spreading acute form of the disease, and indolent NHL, which progresses more slowly. According to the National Cancer Institute's SEER database there were nearly 400,000 people in the U.S. with NHL in 2004. The American Cancer Society estimates that in the United States 66,120 people are expected to be diagnosed with NHL in 2008. Additionally, approximately 19,160 are expected to die from this disease in 2008.

About Cell Therapeutic
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... As one of only 30 Illinois ... and Health Achievement and Recognition Program (SHARP) certification, ... by the Illinois Department of Labor to host this ... SHARP certification by the Occupational Safety and Health Administration’s ... continued to meet or exceed all of the necessary ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 “ ActOn ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... to get connected with organizations to make a difference. , ... are very few things that aren’t about money, which is ...
(Date:5/2/2015)... We are pleased to announce the ... as one of the Top Workplaces of 2015. , ... treatment field for their ethics and standards of excellence. ... continue their educational efforts. The Delray Recovery Center prides ... their purpose – to help individuals heal from the ...
(Date:5/2/2015)... Kare Visits LLC. launched in Chicago in response to ... Visits offers relief for caregivers by visiting loved ones in ... to the Caregiver Action Network, eight in ten caregivers are ... week caring for an elderly or disabled loved one. ... a caregiver is now empowered to schedule an on demand ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 With the success ... company is proud to welcome Neida Miranda and Alex Shields ... Dental Consulting has over 41 years of combined experience working ... been in the dental field for 8 years. She ... in Waco, Texas. Customer service, positive attitude and showing the ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2
... Revenue increases 7 percent to $23 billion -- Diluted earnings per ... EPS from continuing operations ... $0.90 per share -- Full year Non-GAAP ... -- Renews three-year, multi-billon-dollar Walgreens contract, DUBLIN, Ohio, Jan. 29 ...
... 29 , ... -- Net Sales of $1.07 billion represents an increase of 15% reported ... (10% constant currency), -- Diluted EPS were $1.12 reported, ... $1.18 adjusted, an increase of 16% over the prior year ...
... from American College of Surgeons helps patients do the,research ... 29 In today,s information-rich,environment, American consumers are stepping ... more prepared than ever. But according to results of ... consumer survey,when it comes to needing an operation, patients ...
... 29 The American Academy,of Family Physicians is pleased ... interest in improving access to health care. In doing,so, ... system reform., Improving Americans, ability to pay for ... health system that provides care to all, ensures the,financial ...
... Bill Novelli,made the following statement today in response ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070209/NYF043LOGO ), "We hope ... beyond,rhetoric and towards bipartisan solutions that are fair ... together, openly,debate all available options, and solve our ...
... CEO Bill Novelli,made the following statement about today,s ... (Nunez & Perata) by the California State Senate,Committee ... failed to seize an opportunity to,fix their broken ... the,status quo - which includes millions of uninsured ...
Cached Medicine News:Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 2Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 3Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 4Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 5Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 6Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 7Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 8Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 9Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 10Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 11Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 12Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 13Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 14Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 15Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 16Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 17Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 18Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 19Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 20Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 21Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 22Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 23Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 24Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 25Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 26Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 2Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 3Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 4Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 5Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 6Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 7Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 8Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 9Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 10Health News:Zimmer Reports Fourth Quarter and 2007 Financial Results 11
(Date:5/1/2015)... , May 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... Timothy E. Morris , chief financial officer  will be ... events are as follows: Mizuho Third Annual ...  The Omni Berkshire Place, New York ...
(Date:4/30/2015)... Calif., April 30, 2015 Abaxis, Inc. (NasdaqGS: ... blood analysis systems, today reported financial results for the ... Fourth quarter and fiscal 2015 overview: ... the fourth quarter, up 33% over last year,s comparable ... year-over-year. , Diluted EPS of $0.50 for the ...
(Date:4/30/2015)... 2015  Tandem Diabetes Care ® , Inc. (NASDAQ: ... t:slim ® and t:flex™ Insulin Pumps, today reported its ... In comparing the first quarter of 2015 to ... percent to $12.3 million from $8.1 million , t:slim ... pumps "Our investment in resources to build the ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 3Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 4Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 5Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 6Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 7Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 8Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 9Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 10Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 12Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 13Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 14Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 15Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 16Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 17Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 18Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 19Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 20Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 21Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 22Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 23Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 24Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6
... The North Shore-LIJ Health System Department of Radiation Medicine announced ... the mouth) to participate in a Phase I clinical trial. , ... Subjects must be newly diagnosed and ... with the human papilloma virus (HPV-negative), or, if it is HPV-positive, they ...
... July 23 CRF Health garnered nine awards recently in the ... Health Awards, for their bold, new communications aimed at healthcare professionals involved ... the campaign, Langland, at the awards night in London . , ... Judged by some of the ...
Cached Medicine Technology:Study Seeks Volunteers to Measure Safety of Treatment 'Boost' for Patients with Oropharyngeal Cancer 2CRF Health is Awarded for Getting Closer 2CRF Health is Awarded for Getting Closer 3
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
... NuSieve 3:1 Agarose is a molecular biology grade, ... for fine resolution of small DNA, RNA, and ... enhance the speed of gel processing and blotting. ... resolution of DNA fragments up to 1,000 bp, ...
... standard gelling temperature, high gel strength agarose ... bp. This Genetic Technology Grade™ (GTG) agarose ... DNA recovered from SeaKem GTG Agarose gels ... GTG Agarose is extensively performance tested to ...
... gel strength, high electrophoretic mobility, and ... is the superior choice for CHEF ... easy to handle at concentrations as ... run times. Low background staining also ...
Medicine Products: